{"id":"https://openalex.org/W3186872020","doi":"https://doi.org/10.1158/2159-8290.cd-21-0425","title":"Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma","display_name":"Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma","alternate_titles":[],"publication_year":2021,"publication_date":"2021-07-29","ids":{"openalex":"https://openalex.org/W3186872020","doi":"https://doi.org/10.1158/2159-8290.cd-21-0425","mag":"3186872020","pmid":"https://pubmed.ncbi.nlm.nih.gov/34326162","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8799774"},"language":"en","primary_location":{"id":"doi:10.1158/2159-8290.cd-21-0425","doi":"https://doi.org/10.1158/2159-8290.cd-21-0425","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.cd-21-0425","pdf_url":null,"source":{"id":"https://openalex.org/S2486275289","display_name":"Cancer Discovery","issn_l":"2159-8274","issn":["2159-8274","2159-8290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Discovery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3186872020"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1158/2159-8290.cd-21-0425","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083745558","display_name":"Antoni Ribas","orcid":"https://orcid.org/0000-0003-3669-8458","observed_orcids":["https://orcid.org/0000-0003-3669-8458"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Antoni Ribas","raw_affiliation_strings":["1University of California, Los Angeles, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Theresa Medina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Theresa Medina","raw_affiliation_strings":["2University of Colorado Cancer Center, Aurora, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Colorado Cancer Center, Aurora, Colorado","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007239425","display_name":"John M. Kirkwood","orcid":"https://orcid.org/0000-0002-3570-4476","observed_orcids":["https://orcid.org/0000-0002-3570-4476"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John M. Kirkwood","raw_affiliation_strings":["3University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania"],"raw_orcid":"https://orcid.org/0000-0002-3570-4476","affiliations":[{"raw_affiliation_string":"3University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I4210128526","https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049546835","display_name":"Yousef Zakharia","orcid":"https://orcid.org/0000-0001-9480-2626","observed_orcids":["https://orcid.org/0000-0001-9480-2626"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yousef Zakharia","raw_affiliation_strings":["4University of Iowa, Iowa City, Iowa"],"raw_orcid":"https://orcid.org/0000-0001-9480-2626","affiliations":[{"raw_affiliation_string":"4University of Iowa, Iowa City, Iowa","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rene Gonzalez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rene Gonzalez","raw_affiliation_strings":["2University of Colorado Cancer Center, Aurora, Colorado"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Colorado Cancer Center, Aurora, Colorado","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030169825","display_name":"Diwakar Davar","orcid":"https://orcid.org/0000-0002-7846-8055","observed_orcids":["https://orcid.org/0000-0002-7846-8055"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Diwakar Davar","raw_affiliation_strings":["3University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania"],"raw_orcid":"https://orcid.org/0000-0002-7846-8055","affiliations":[{"raw_affiliation_string":"3University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I4210128526","https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039301683","display_name":"Bartosz Chmielowski","orcid":"https://orcid.org/0000-0002-2374-3320","observed_orcids":["https://orcid.org/0000-0002-2374-3320"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bartosz Chmielowski","raw_affiliation_strings":["1University of California, Los Angeles, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0002-2374-3320","affiliations":[{"raw_affiliation_string":"1University of California, Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052134884","display_name":"Katie Marie Campbell","orcid":"https://orcid.org/0000-0001-6491-4432","observed_orcids":["https://orcid.org/0000-0001-6491-4432"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Katie M. Campbell","raw_affiliation_strings":["1University of California, Los Angeles, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0001-6491-4432","affiliations":[{"raw_affiliation_string":"1University of California, Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Riyue Bao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Riyue Bao","raw_affiliation_strings":["3University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I4210128526","https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Heather Kelley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Heather Kelley","raw_affiliation_strings":["5Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Aaron Morris","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aaron Morris","raw_affiliation_strings":["5Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Mauro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Mauro","raw_affiliation_strings":["5Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"James E. Wooldridge","orcid":"https://orcid.org/0000-0002-9940-8238","observed_orcids":["https://orcid.org/0000-0002-9940-8238"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James E. Wooldridge","raw_affiliation_strings":["5Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":"https://orcid.org/0000-0002-9940-8238","affiliations":[{"raw_affiliation_string":"5Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063337705","display_name":"Jason J. Luke","orcid":"https://orcid.org/0000-0002-1182-4908","observed_orcids":["https://orcid.org/0000-0002-1182-4908"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jason J. Luke","raw_affiliation_strings":["3University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I4210128526","https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":null,"display_name":"George J. Weiner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"George J. Weiner","raw_affiliation_strings":["4University of Iowa, Iowa City, Iowa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Iowa, Iowa City, Iowa","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Arthur M. Krieg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arthur M. Krieg","raw_affiliation_strings":["5Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089777560","display_name":"Mohammed M. Milhem","orcid":"https://orcid.org/0000-0003-4663-6824","observed_orcids":["https://orcid.org/0000-0003-4663-6824"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mohammed M. Milhem","raw_affiliation_strings":["4University of Iowa, Iowa City, Iowa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Iowa, Iowa City, Iowa","institution_ids":["https://openalex.org/I126307644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5083745558"],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":9.9348,"has_fulltext":true,"cited_by_count":197,"citation_normalized_percentile":{"value":0.99116978,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"11","issue":"12","first_page":"2998","last_page":"3007"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cpg-a","display_name":"CpG-A","score":0.7820000052452087},{"id":"https://openalex.org/keywords/toll-like-receptor-9-agonist","display_name":"Toll-like receptor 9 agonist","score":0.9879999756813049},{"id":"https://openalex.org/keywords/anti-pd-1-resistance","display_name":"anti-PD-1 resistance","score":0.9290000200271606},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.953000009059906},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/intratumoral-immunotherapy","display_name":"intratumoral immunotherapy","score":0.6819999814033508},{"id":"https://openalex.org/keywords/interferon-gamma-response","display_name":"interferon-gamma response","score":0.7730000019073486},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.9549999833106995},{"id":"https://openalex.org/keywords/virus-like-particles","display_name":"virus-like particles","score":0.6150000095367432},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7250000238418579},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.8223999738693237},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.7820000052452087},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.737500011920929},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7190999984741211},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6917999982833862},{"id":"https://openalex.org/C2779138994","wikidata":"https://www.wikidata.org/wiki/Q15332550","display_name":"TLR9","level":5,"score":0.6044999957084656},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5491999983787537},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.446399986743927},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4185999929904938},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3395000100135803},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.3221000134944916},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.31119999289512634},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.2937999963760376},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.2863999903202057},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.2680000066757202},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.26510000228881836},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.2556999921798706},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2556000053882599}],"mesh":[{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051217","descriptor_name":"Toll-Like Receptor 9","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/2159-8290.cd-21-0425","doi":"https://doi.org/10.1158/2159-8290.cd-21-0425","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.cd-21-0425","pdf_url":null,"source":{"id":"https://openalex.org/S2486275289","display_name":"Cancer Discovery","issn_l":"2159-8274","issn":["2159-8274","2159-8290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Discovery","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8799774","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8799774/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8799774/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Discov","raw_type":"Text"},{"id":"pmid:34326162","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34326162","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer discovery","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt58n925qq","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/58n925qq","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Discovery, vol 11, iss 12","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1158/2159-8290.cd-21-0425","doi":"https://doi.org/10.1158/2159-8290.cd-21-0425","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.cd-21-0425","pdf_url":null,"source":{"id":"https://openalex.org/S2486275289","display_name":"Cancer Discovery","issn_l":"2159-8274","issn":["2159-8274","2159-8290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Discovery","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G3992574355","display_name":"Combination Therapies to Defeat Melanoma Resistance","funder_award_id":"P01CA244118","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000881001","display_name":"UCLA Tumor Immunology Institutional Training Grant","funder_award_id":"T32CA009120","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000883691","display_name":"Next Generation Cancer Immunotherapies to Defeat Melanoma","funder_award_id":"R35CA197633","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000897317","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA047904","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306155","display_name":"Cancer Research Institute","ror":"https://ror.org/02f3xk561"},{"id":"https://openalex.org/F4320315119","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3186872020.pdf","grobid_xml":"https://content.openalex.org/works/W3186872020.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W7468802","https://openalex.org/W1508239850","https://openalex.org/W1652582743","https://openalex.org/W1818618334","https://openalex.org/W1836917557","https://openalex.org/W1988555834","https://openalex.org/W2032639905","https://openalex.org/W2039123767","https://openalex.org/W2070490291","https://openalex.org/W2118796952","https://openalex.org/W2137540618","https://openalex.org/W2143523733","https://openalex.org/W2170612601","https://openalex.org/W2296049142","https://openalex.org/W2555275271","https://openalex.org/W2587048937","https://openalex.org/W2588686192","https://openalex.org/W2655262992","https://openalex.org/W2750781282","https://openalex.org/W2775143705","https://openalex.org/W2800340935","https://openalex.org/W2888914203","https://openalex.org/W2897815318","https://openalex.org/W2999363115","https://openalex.org/W3032544449","https://openalex.org/W3083580449","https://openalex.org/W3164503428"],"related_works":["https://openalex.org/W3211713809","https://openalex.org/W4412867643","https://openalex.org/W4409117972","https://openalex.org/W4399122615","https://openalex.org/W4200109413","https://openalex.org/W7154965167","https://openalex.org/W4296558398","https://openalex.org/W4403935394","https://openalex.org/W4403925979","https://openalex.org/W7025231087"],"abstract_inverted_index":{"Patients":[0,115],"with":[1,63,69,103,155,164],"advanced":[2,70,156],"melanoma":[3,71],"that":[4],"is":[5,203],"resistant":[6],"to":[7,40,66,118,183],"PD-1":[8,31,185],"blockade":[9,32,186],"therapy":[10],"have":[11],"limited":[12],"treatment":[13],"options.":[14],"Vidutolimod":[15],"(formerly":[16],"CMP-001),":[17],"a":[18,22,36,90,167],"virus-like":[19],"particle":[20],"containing":[21],"CpG-A":[23],"Toll-like":[24],"receptor":[25],"9":[26],"(TLR9)":[27],"agonist,":[28],"may":[29],"reverse":[30],"resistance":[33,187],"by":[34,197],"triggering":[35],"strong":[37],"IFN":[38,192],"response":[39],"induce":[41],"and":[42,87,94,109,120,127,171],"attract":[43],"antitumor":[44],"T":[45],"cells.":[46],"In":[47,148,207],"the":[48,143,177,206],"dose-escalation":[49],"part":[50],"of":[51,85,101,129,142,181,190],"this":[52,149],"phase":[53,150],"Ib":[54,151],"study,":[55],"vidutolimod":[56,86,119,161,182],"was":[57],"administered":[58],"intratumorally":[59],"at":[60,125],"escalating":[61],"doses":[62],"intravenous":[64],"pembrolizumab":[65,88,121,165],"44":[67],"patients":[68,154],"who":[72,116],"had":[73,89,122,166],"progressive":[74],"disease":[75,78],"or":[76],"stable":[77],"on":[79],"prior":[80],"anti-PD-1":[81],"therapy.":[82],"The":[83],"combination":[84,163],"manageable":[91,168],"safety":[92,169],"profile,":[93],"durable":[95],"responses":[96],"were":[97],"observed":[98],"in":[99,106,153,162,205],"25%":[100],"patients,":[102],"tumor":[104],"regression":[105],"both":[107],"injected":[108],"noninjected":[110],"lesions,":[111],"including":[112],"visceral":[113],"lesions.":[114],"responded":[117],"noninflamed":[123],"tumors":[124],"baseline":[126],"induction":[128,189],"an":[130,191],"IFN\u03b3":[131],"gene":[132],"signature":[133],"following":[134],"treatment,":[135],"as":[136,138],"well":[137],"increased":[139],"systemic":[140],"expression":[141],"IFN-inducible":[144],"chemokine":[145],"CXCL10.":[146],"SIGNIFICANCE:":[147],"study":[152],"melanoma,":[157],"intratumoral":[158],"TLR9":[159],"agonist":[160],"profile":[170],"showed":[172],"promising":[173],"clinical":[174,179],"activity,":[175],"supporting":[176],"further":[178],"development":[180],"overcome":[184],"through":[188],"response.":[193],"See":[194],"related":[195],"commentary":[196],"Sullivan,":[198],"p.":[199,211],"2960.":[200],"This":[201,208],"article":[202],"highlighted":[204],"Issue":[209],"feature,":[210],"2945.":[212]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3186872020","counts_by_year":[{"year":2026,"cited_by_count":44},{"year":2025,"cited_by_count":45},{"year":2024,"cited_by_count":32},{"year":2023,"cited_by_count":33},{"year":2022,"cited_by_count":39},{"year":2021,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2021-08-02T00:00:00"}
